Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2017 09:25 ET | Source: Galena Biopharma, Inc.

Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio

SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting...
December 14, 2017 17:03 ET | Source: Galena Biopharma, Inc.

Galena Will Adjourn Special Meeting until Friday, December 29, 2017, Urges Stockholders to Vote

SAN RAMON, Calif., Dec. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), (“Galena”) announced today that its special meeting of stockholders (“Special Meeting”), scheduled for...
December 08, 2017 14:50 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017

SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination...
November 09, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Third Quarter 2017 Financial Results

SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
September 28, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

SAN RAMON, Calif., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
September 11, 2017 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership

SAN RAMON, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
August 14, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Second Quarter 2017 Financial Results

SAN RAMON, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
August 08, 2017 06:00 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Enters into Merger Agreement with SELLAS Life Sciences Group

Merger to create a late-stage, NASDAQ-listed company focused on developing novel immune therapies for various types of cancerSELLAS’ lead asset, galinpepimut-S (GPS), is a Wilm’s Tumor 1...
July 12, 2017 06:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Provides Corporate Update

SAN RAMON, Calif., July 12, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...
May 10, 2017 16:30 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports First Quarter 2017 Financial Results

SAN RAMON, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical...

Next Page keyboard_arrow_right